PDCD1LG2 and gastric cancer: Among the 340 GC patients for whom IHC staining was conducted, twenty-one GC patients were randomly selected from the ‘EBV positive’ (7 cases) and ‘EBV negative’ (14 cases) groups to determine PD-1, PD-L1, and PD-L2 mRNA expression by qRT-PCR.